Video

Basal Cell Carcinoma Clinical Pearls

Author(s):

Jennifer L. Atlas, MD,Shahab Babakoohi, MD

Drs Babakoohi and Atlas share clinical pearls for community oncologists on treating basal cell carcinoma.

Related Videos
Bartosz Chmielowski, MD
Michael A. Postow, MD
Matthew P. Deek, MD
Thach-Giao Truong, MD
Thach-Giao Truong, MD, medical director, Melanoma Program, Cleveland Clinic
Alexander C. Van Akkooi, MD, PhD, FRACS
Meredith McKean, MD
Ahmad Tarhini, MD, PhD
Ahmad Tarhini, MD, PhD
Georgina V. Long, MBBS, PhD, FRACP
Related Content
FDA
January 21st 2025

FDA Grants Priority Review to RP1 Plus Nivolumab for Advanced Melanoma After Anti–PD-1 Therapy

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Basal Cell Carcinoma | Maris– stock.adobe.com
January 8th 2025

Phase 3 Study of Ameluz-PDT in Superficial Basal Cell Carcinoma Reaches 1-Year Follow-Up to Support FDA sNDA Submission

Jeffrey S. Weber, MD, PhD
November 6th 2023

FDA Approval Insights: Adjuvant Nivolumab in Completely Resected Stage IIB/C Melanoma

Melanoma | Maris– stock.adobe.com
January 4th 2025

BMS-986253 Plus Nivolumab/Ipilimumab Fails to Boost Responses in Advanced Melanoma After Prior Anti–PD-(L)1 Therapy

Lynn M. Schuchter, MD
January 1st 2025

A 30-Year Commitment to Advancing Melanoma Care